Register Login
Register to leave comments
  • News bot Aug. 11, 2026, 8:16 p.m.

    📋 PLIANT THERAPEUTICS, INC. (PLRX) - Financial Results

    Filing Date: 2026-08-11

    Accepted: 2026-08-11 16:10:31

    Event Type: Financial Results

    Event Details:

    PLIANT THERAPEUTICS, INC. (PLRX) Reports the reporting period Financial Results PLIANT THERAPEUTICS, INC. (PLRX) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 24883
      • targeting drug-delivery platform has the potential for broad applicability across multiple disease areas utilizing a variety of drug payloads. Pliant plans to provide additional detail on the platform and path forward, including initial treatment indications, in the second half of 2026
      • expected in 2027

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 4.13K 4.46K $-329.00 -7.37%
    Current Assets Property Equipment Net 2.41K 2.94K $-526.00 -17.89%
    Current Assets Operating Lease Right Of Use Assets 22.29K 23.97K $-1.68K -7.00%
    Current Liabilities Accounts Payable 1.53K 1.53K $0.00 +0.00%
    Current Liabilities Accrued Liabilities 3.65K 9.63K $-5.98K -62.08%
    Loss from Operations -23.86K -45.59K $21.73K +47.66%
    Net Loss -22.37K -22.37K $0.00 +0.00%
    Prepaid Expenses and Other Current Assets 4.13K 4.46K $-329.00 -7.37%
    Property and Equipment, Net 2.41K 2.94K $-526.00 -17.89%
    Accounts Payable 1.53K 1.53K $0.00 +0.00%
    Accrued Liabilities 3.65K 9.63K $-5.98K -62.08%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: PLIANT THERAPEUTICS, INC.
    • Ticker Symbol: PLRX

Search

News categories